{"mainPropery":{"diseaseId":540,"diseaseName":"Medium-chain acyl-coenzyme A dehydrogenase deficiency","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/540/medium-chain-acyl-coenzyme-a-dehydrogenase-deficiency","synonyms":["MCAD deficiency","Acyl-CoA dehydrogenase medium chain deficiency of","MCADH deficiency","ACADM deficiency","MCADD","Medium chain acyl CoA dehydrogenase deficiency","Medium-chain acyl-CoA dehydrogenase deficiency"],"synonyms-with-source":[{"name":"MCAD deficiency"},{"name":"Acyl-CoA dehydrogenase medium chain deficiency of"},{"name":"MCADH deficiency"},{"name":"ACADM deficiency"},{"name":"MCADD"},{"name":"Medium chain acyl CoA dehydrogenase deficiency"},{"name":"Medium-chain acyl-CoA dehydrogenase deficiency"}],"identifiers":[{"identifierType":"OMIM","identifierId":"201450"},{"identifierType":"ORPHANET","identifierId":"42"},{"identifierType":"UMLS","identifierId":"C0220710"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":14,"diseaseTypeName":"Metabolic disorders"},{"diseaseTypeId":37,"diseaseTypeName":"Newborn Screening"}],"organizations":[{"resourceID":138,"resourceName":"Metabolic Support UK","abbreviation":"","address1":"5 Hilliards Court","address2":"Sandpiper Way","address3":"Chester Business Park","address4":"","address5":"","city":"Chester","state":"","zip":"CH4 9QP","country":"United Kingdom","phone":"0845 241 2173","tty":"","tollFree":"0800 652 3181 ","fax":"","email":"https://www.metabolicsupportuk.org/contact-us","url":"https://www.metabolicsupportuk.org","freeText":""},{"resourceID":175,"resourceName":"FOD (Fatty Oxidation Disorder) Family Support Group","abbreviation":"","address1":"P.O. Box 54","address2":"","address3":"","address4":"","address5":"","city":"Okemos","state":"MI","zip":"48805-0054","country":"United States","phone":"+1-517-381-1940 [8am - 8pm EST every day]","tty":"","tollFree":"","fax":"+1-866-290-5206","email":"deb@fodsupport.org","url":"https://fodsupport.org/","freeText":""},{"resourceID":176,"resourceName":"United Mitochondrial Disease Foundation","abbreviation":"","address1":"8085 Saltsburg Road, Suite 201","address2":"","address3":"","address4":"","address5":"","city":"Pittsburgh","state":"PA","zip":"15239 ","country":"United States","phone":"+1-412-793-8077 ","tty":"","tollFree":"1-888-317-8633","fax":"+1-412-793-6477 ","email":"info@umdf.org","url":"https://www.umdf.org","freeText":""},{"resourceID":221,"resourceName":"Organic Acidemia Association","abbreviation":"","address1":"9040 Duluth Street","address2":"","address3":"","address4":"","address5":"","city":"Golden Valley","state":"MN","zip":"55427","country":"United States","phone":"763-559-1797","tty":"","tollFree":"","fax":"866-539-4060","email":"mkstagni@gmail.com","url":"http://www.oaanews.org/","freeText":""},{"resourceID":694,"resourceName":"MitoAction","abbreviation":"","address1":"PO Box 51474","address2":"","address3":"","address4":"","address5":"","city":"Boston","state":"MA","zip":"02205","country":"United States","phone":"1-888-MITO-411 (648-6411) for support line","tty":"","tollFree":"1-888-648-6228","fax":"","email":"info@mitoaction.org","url":"https://www.mitoaction.org/","freeText":""},{"resourceID":705,"resourceName":"Genetic Metabolic Dietitians International","abbreviation":"","address1":"P.O. Box 1462","address2":"","address3":"","address4":"","address5":"","city":"Hillsborough","state":"NC","zip":"27278","country":"United States","phone":"","tty":"","tollFree":"","fax":"","email":"info@gdmi.org","url":"http://www.gmdi.org/ ","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/201450' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='https://www.ncbi.nlm.nih.gov/pubmed/?term=Medium-chain+acyl-coenzyme+A+dehydrogenase+deficiency+%5Bti%5D' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Medium-chain acyl-coenzyme A dehydrogenase deficiency. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition=mediumchainacylcoenzymeadehydrogenasedeficiency' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Medium-chain acyl-coenzyme A dehydrogenase deficiency. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":350,"resourceId":1167,"resourceName":"Baby's First Test","descriptionText":"<a href='https://www.babysfirsttest.org/newborn-screening/conditions/medium-chain-acyl-coa-dehydrogenase-deficiency' target='_blank'>Baby's First Test</a> is the nation's newborn screening education center for families and providers. This site provides information and resources about screening at the local, state, and national levels and serves as the Clearinghouse for newborn screening information.","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Newborn Screening"},{"id":892,"resourceId":1594,"resourceName":"Genetic Metabolic Dietitians International","descriptionText":"<a href='http://www.gmdi.org/Resources/Nutrition-Guidelines/MCAD' target='_blank'>Genetic Metabolic Dietitians International (GMDI)</a> has developed nutrition guidelines for this condition.","resourceClassificationName":"Treatment","resourceClassificationSectionName":"Management Guidelines"},{"id":1264,"resourceId":176,"resourceName":"United Mitochondrial Disease Foundation","descriptionText":"You can submit a question to <a href='http://pi.umdf.org/l/346741/2017-11-01/7vxq' target='_blank'>Ask the Mito Doc</a>, a service of the United Mitochondrial Diseases Foundation. Information contained in Ask the Mito Doc<small><sup>SM</sup></small> is for informational and educational purposes only.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1316,"resourceId":1977,"resourceName":"Free full text - Wang, et al. MCAD def","descriptionText":"Wang, et al. <a href='http://pediatrics.aappublications.org/cgi/reprint/105/5/1175?maxtoshow=&amp;amp;HITS=10&amp;amp;hits=10&amp;amp;RESULTFORMAT=&amp;amp;fulltext=medium-chain&amp;amp;searchid=1&amp;amp;FIRSTINDEX=0&amp;amp;volume=105&amp;amp;issue=5&amp;amp;resourcetype=HWCIT ' target='_blank'>Is the G985A Allelic Variant of Medium-Chain Acyl-CoA Dehydrogenase a Risk Factor for Sudden Infant Death Syndrome? A Pooled Analysis</a>. Pediatrics. 2000;105:1175-1176.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Selected Full-Text Journal Articles"},{"id":1321,"resourceId":1982,"resourceName":"National Newborn Screening and Global Resource Center","descriptionText":"<a href='https://www.newbornscreening.info/iva-isovaleric-acidemia/' target='_blank'>National Newborn Screening and Global Resource Center</a> (NNSGRC) provides information and resources in the area of newborn screening and genetics to benefit health professionals, the public health community, consumers and government officials.","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Newborn Screening"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/gtr/conditions/C0220710' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/585/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/946755-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=42' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1535,"resourceId":2166,"resourceName":"ACTion (ACT) sheet","descriptionText":"An  <a href='https://www.acmg.net/PDFLibrary/C8-C6-C10.pdf' target='_blank'>ACTion (ACT) sheet </a> is available for this condition that describes the short-term actions a health professional should follow when an infant has a positive newborn screening result. ACT sheets were developed by experts in collaboration with the American College of Medical Genetics.","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Newborn Screening"},{"id":1537,"resourceId":2168,"resourceName":"GeneReviews","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=mcad' target='_blank'>GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1539,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='https://www.orpha.net/consor/cgi-bin/ResearchTrials_ClinicalTrials_Simple.php?lng=EN&LnkId=3570&Typ=Pat&fdp=y&from=rightMenu' target='_blank'>Orphanet</a> lists European clinical trials, research studies, and patient registries enrolling people with this condition.&nbsp;","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1541,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/ClinicalLabs_Search_Simple.php?lng=EN&LnkId=3570&Typ=Pat' target='_blank'>Orphanet</a> lists international laboratories offering diagnostic testing for this condition.","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1542,"resourceId":2170,"resourceName":"RePORTER","descriptionText":"The <a href='http://projectreporter.nih.gov/reporter.cfm' target='_blank'>Research Portfolio Online Reporting Tool (RePORT)</a> provides access to reports, data, and analyses of research activities at the National Institutes of Health (NIH), including information on NIH expenditures and the results of NIH-supported research.  Although these projects may not conduct studies on humans, you may want to contact the investigators to learn more. To search for studies, enter the disease name in the \"Text Search\" box.  Then click \"Submit Query\".","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1546,"resourceId":2174,"resourceName":"Algorithm","descriptionText":"An <a href='https://www.acmg.net/ACMG/ACMG/UploadedPDFS/PDFDocuments/C8-Elevated-Lesser-Elevations-of-C6-and-C10.aspx' target='_blank'>Algorithm</a> flowchart is available for this condition for determining the final diagnosis in an infant with a positive newborn screening result. Algorithms are developed by experts in collaboration with the American College of Medical Genetics.","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Newborn Screening"},{"id":1547,"resourceId":2175,"resourceName":"Screening, Technology And Research in Genetics (STAR-G) Project","descriptionText":"The <a href='http://www.newbornscreening.info/Parents/fattyaciddisorders/MCADD.html' target='_blank'>Screening, Technology And Research in Genetics (STAR-G) Project</a> has a fact sheet on this condition, which was written specifically for families that have received a diagnosis as a result of newborn screening. This fact sheet provides general information about the condition and answers questions that are of particular concern to parents.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1702,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='https://www.orpha.net/data/patho/Pro/en/Emergency_BIMDG_MCADdeficiency-enPro3570.pdf' target='_blank'>Orphanet Emergency Guidelines</a> is an article which is expert-authored and peer-reviewed that is intended to guide health care professionals in emergency situations involving this condition. &nbsp;","resourceClassificationName":"Treatment","resourceClassificationSectionName":"Management Guidelines"},{"id":1713,"resourceId":2858,"resourceName":"International Network for Fatty Acid Oxidation Research and Management","descriptionText":"The&nbsp;<a href='https://informnetwork.org/annual-conference-new/' target='_blank'>International Network for Fatty Acid Oxidation Research and Management</a> (INFORM) was formed in order to promote research and discussion into the cause, diagnosis, and management of fatty acid oxidation disorders (FAODs). They offer several learning opportunities throughout the year for patients, families, and researchers. INFORM's Annual Meeting will  be held on August 30th and 31st, 2020 in Freiberg, Germany preceding the Society for the Study of Inborn Errors of Metabolism (SSIEM). The Network also continues to provide a collaborative framework for ongoing communication and research regarding FAODs.","resourceClassificationName":"News & Events","resourceClassificationSectionName":"Other Conferences"},{"id":1846,"resourceId":3031,"resourceName":"Genetics Education Materials for School Success","descriptionText":"The <a href='http://www.gemssforschools.org/conditions/mcad/default' target='_blank'>Genetics Education Materials for School Success (GEMSS)</a> aims to assure that all children with genetic health conditions succeed in school-life. Their Web site offers general and condition-specific education resources to help teachers and parents better understand the needs of students who have genetic conditions.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Education Resources"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:201450' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":1259,"questionText":"What is medium-chain acyl-coenzyme A dehydrogenase (MCAD) deficiency?","answerText":"<strong>Medium-chain acyl-coenzyme A dehydrogenase deficiency (MCADD)</strong> is an inherited metabolic disorder that prevents the body from converting certain fats to energy, particularly during periods without food (fasting). People with MCADD do not have enough of an enzyme needed to metabolize a group of fats called medium-chain fatty acids. Signs and symptoms usually begin by early childhood and may include vomiting, lack of energy, and low blood sugar (hypoglycemia). Symptoms can be triggered by periods of fasting or by illnesses.[757]<br />\r\n<br />\r\nMCADD is caused by mutations in the&nbsp;<a class=\"link-dapple\" title=\"A C A D M\" href=\"http://ghr.nlm.nih.gov/gene=acadm\" target=\"_blank\"><em>ACADM</em></a>&nbsp;gene and inheritance is <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a>.[757] Treatment includes strict avoidance of fasting and avoidance of medium chain triglycerides in the diet.[7514] If not treated, people with MCADD are at risk of serious complications including sudden death.[757]<br />","dateModified":"2017-08-29T00:00:00"},"basicQuestions":[{"questionId":1265,"questionText":"What are the signs and symptoms of medium-chain acyl-coenzyme A dehydrogenase (MCAD) deficiency?","answerText":"The initial signs and symptoms of medium-chain acyl-coenzyme A dehydrogenase deficiency (MCADD) typically occur during infancy or early childhood and can include vomiting, lack of energy (lethargy), and low blood sugar (hypoglycemia). In rare cases, the first episode of problems related to MCADD occurs during adulthood. The signs and symptoms of MCADD can be triggered by periods of fasting, or during illnesses such as viral infections, particularly when eating is reduced. People with MCADD are also at risk of serious complications such as seizures, breathing difficulties, liver problems, brain damage, coma, and sudden, unexpected death.[757]","dateModified":"2017-08-29T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":757,"authors":"","articleTitle":"Medium-chain acyl-coenzyme A dehydrogenase deficiency","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"February, 2015","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition=mediumchainacylcoenzymeadehydrogenasedeficiency","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1423,"questionText":"What causes&nbsp;medium-chain acyl-coenzyme A dehydrogenase (MCAD) deficiency?","answerText":"MCADD is caused by mutations in the <a class=\"link-dapple\" title=\"A C A D M\" href=\"http://ghr.nlm.nih.gov/gene=acadm\" target=\"_blank\"><span><em>ACADM</em></span></a> gene. This gene gives the body instructions for making an enzyme called medium-chain acyl-CoA dehydrogenase, needed to break down fats called medium-chain fatty acids. These fatty acids are found in foods and the body's tissues, and are an important source of energy for the heart, muscles, liver, and other tissues. Mutations in this gene lead to low levels of the enzyme, which means that medium-chain fatty acids are not broken down properly. They cannot be converted to energy, leading to the symptoms of MCADD.[757]","dateModified":"2017-08-29T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":757,"authors":"","articleTitle":"Medium-chain acyl-coenzyme A dehydrogenase deficiency","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"February, 2015","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition=mediumchainacylcoenzymeadehydrogenasedeficiency","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1424,"questionText":"How is&nbsp;medium-chain acyl-coenzyme A dehydrogenase (MCAD) deficiency inherited?","answerText":"Medium-chain acyl-coenzyme A dehydrogenase deficiency (MCADD) is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> manner.[757] This means that to have MCADD, a person must have a&nbsp;<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutation</a>&nbsp;in both copies of the responsible&nbsp;<a href=\"http://www.genome.gov/glossary/index.cfm?id=70\" target=\"_blank\">gene</a>&nbsp;in each cell. There is nothing either parent can do, before or during a pregnancy, to cause a child to have this condition.<br />\r\n<br />\r\nPeople with MCADD inherit one mutation from each of their parents. The parents, who each have one mutation, are known as&nbsp;<a href=\"https://www.genome.gov/glossary/?id=23\" target=\"_blank\">carriers</a>. Carriers of an autosomal recessive condition typically do not have any signs or symptoms (they are unaffected). When 2 carriers of an autosomal recessive condition have children, each child has a:\r\n<ul>\r\n    <li>25% chance to have the condition</li>\r\n    <li>50% chance to be an unaffected carrier like each parent</li>\r\n    <li>25% chance to be unaffected&nbsp;<em>and</em>&nbsp;not a carrier</li>\r\n</ul>","dateModified":"2017-08-29T00:00:00","resourceClassificationName":"Inheritance","references":[{"referenceId":757,"authors":"","articleTitle":"Medium-chain acyl-coenzyme A dehydrogenase deficiency","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"February, 2015","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition=mediumchainacylcoenzymeadehydrogenasedeficiency","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1260,"questionText":"How is&nbsp;medium-chain acyl-coenzyme A dehydrogenase deficiency (MCADD) diagnosed?","answerText":"A diagnosis of MCADD requires an evaluation of a person's symptoms as well as the interpretation of several tests. Initial testing may include:<br />\r\n<ul>\r\n    <li>Plasma acylcarnitine</li>\r\n    <li>Urine organic acid </li>\r\n    <li>Urine acylglycine</li>\r\n</ul>\r\nFurther testing to confirm the diagnosis may include molecular genetic testing of the <em>ACADM</em> gene or biochemical genetic testing.[13748]<br />\r\n<br />\r\nMCADD is  included in many <a href=\"https://www.cdc.gov/newbornscreening/\" target=\"_blank\">newborn screening programs</a>, so a newborn with MCADD who does not yet exhibit symptoms may be diagnosed early. If a newborn screening result for MCADD is not in the normal range (\"positive\"), additional testing can then be ordered.[7514]","dateModified":"2017-08-29T00:00:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":7514,"authors":"Simon Olpin","articleTitle":"Medium chain acyl-CoA dehydrogenase deficiency","bookWebsiteJournalTitle":"Orphanet","date":"February, 2014","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=EN&Expert=42","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13748,"authors":"Matern D, Rinaldo P","articleTitle":"Medium-Chain Acyl-Coenzyme A Dehydrogenase Deficiency","bookWebsiteJournalTitle":"GeneReviews","date":"March 5, 2015","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK1424/","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[],"gardCases":[{"caseId":46493,"abbreviatedInquiry":"I am wondering if there is any information about children suffering from MCADD experiencing white stools for any reason related to the metabolic disorder. Is this a sign that my daughter is getting fat build-up on her heart, brain, or liver? Please let me know what you think.","caseQuestions":[{"questionId":7600,"questionText":"Is white stool known to be associated with medium-chain acyl-coenzyme A dehydrogenase deficiency (MCADD)?","answerText":"We are not aware of an association between white stool and MCADD, or of reports of people with MCADD having white stools.<br />\r\n<br />\r\nStool color is generally influenced by what a person eats, as well as by the amount of bile in the stool. Bile is a yellow-green fluid produced by the liver that digests fats. As bile travels through the gastrointestinal tract, it becomes chemically altered by enzymes, which normally change the color from green to brown.[7518]<br />\r\n<br />\r\nLight-colored, white, or clay-colored stool could indicate a lack of bile in the stool. This is sometimes due to having a bile duct obstruction, or another problem with how the liver is functioning. Certain medications can also cause light-colored stools such as large doses of bismuth subsalicylate (Kaopectate, Pepto-Bismol) and other anti-diarrheal drugs.[7518]<br />\r\n<br />\r\nAny sudden, or gradual, persistent changes in stool color should be evaluated by a medical professional to make sure the changes are not caused by an underlying medical problem.","dateModified":"2014-07-08T00:00:00","references":[{"referenceId":7518,"authors":"Michael F. Picco","articleTitle":"Stool color: when to worry","bookWebsiteJournalTitle":"Mayo Clinic","date":"October 12, 2012","volume":"","pages":"","url":"","dateAccessed":"2014-07-07T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]}]},{"caseId":31483,"abbreviatedInquiry":"My daughter was diagnosed with medium-chain acyl-coenzyme A dehydrogenase deficiency at 2 weeks. She is now 10 weeks old and seems to eat a lot. She's having breast and bottle milk but can drink 80z of hungry baby formula.&nbsp;Is it&nbsp;normal for her to be hungry all the time?&nbsp;Also, what happens to the fats&nbsp;as she can't break them down further?","caseQuestions":[{"questionId":4919,"questionText":"What happens to the fats&nbsp;when a baby with&nbsp;medium-chain acyl-coenzyme A dehydrogenase deficiency (MCADD) cannot break them down? ","answerText":"<p>Medium chain acyl-CoA dehydrogenase deficiency&nbsp;is a&nbsp;<a href=\"http://www.newbornscreening.info/GlossaryTerms/fattyAcidOxidationDisorder.html\" target=_blank><u>fatty acid oxidation disorder</u></a>&nbsp;in which people have&nbsp;problems breaking down <u><a href=\"http://www.newbornscreening.info/GlossaryTerms/fat.html\" target=_blank>fat</a></u> into energy for the body.&nbsp;It is&nbsp;caused by an&nbsp;<a href=\"http://www.newbornscreening.info/GlossaryTerms/enzyme.html\" target=_blank><u>enzyme</u></a> that does not work properly.&nbsp;MCADD occurs when an <a href=\"http://www.newbornscreening.info/GlossaryTerms/enzyme.html\" target=_blank><u>enzyme</u></a>, called medium chain acyl-CoA dehydrogenase, is either missing or not working properly. This enzyme’s job is to break down certain fats in food into energy. It also breaks down fat already stored in the body.&nbsp;Energy from fat keeps us going whenever our bodies run low of their main source of energy, a type of sugar called <a href=\"http://www.newbornscreening.info/GlossaryTerms/glucose.html\" target=_blank><u>glucose</u></a>. Our bodies rely on fat when we don’t eat for a stretch of time – like when we miss a meal or when we sleep.[3905]&nbsp; </p>When the medium chain acyl-CoA dehydrogenase enzyme is missing or not working well, the body cannot use certain types of fat for energy, and must rely solely on glucose. Although glucose is a good source of energy, there is a limited amount available. Once the glucose has been used up, the body tries to use fat without success. This leads to low blood sugar, called <a href=\"http://www.newbornscreening.info/GlossaryTerms/hypoglycemia.html\" target=_blank><u>hypoglycemia</u></a>, and to the build up of harmful substances in the blood, which can lead to&nbsp;<a href=\"http://www.newbornscreening.info/GlossaryTerms/metabolicCrisis.html\" target=_blank><u>metabolic crises</u></a>. Symptoms often happen after having nothing to eat for more than a few hours. Hypoglycemia can occur, with or without other symptoms of metabolic crisis, just by going too long without food. Hypoglycemia can cause a person to feel weak, shaky, or dizzy, and to have clammy, cold skin. If not treated, hypoglycemia can lead to coma and even death.[3905]","dateModified":"2011-07-15T16:32:00","references":[{"referenceId":3905,"authors":"","articleTitle":"Genetic Fact Sheets for Parents: Fatty Acid Oxidation Disorders","bookWebsiteJournalTitle":"STAR-G","date":"April 2011","url":"http://www.newbornscreening.info/Parents/fattyaciddisorders/MCADD.html","dateAccessed":"2011-07-15T00:00:00"}]},{"questionId":4918,"questionText":"Is it normal for a baby with medium-chain acyl-coenzyme A dehydrogenase deficiency (MCADD) to be hungry all the time?","answerText":"Infants and young children with MCADD need to eat frequently to prevent <a href=\"http://www.nlm.nih.gov/medlineplus/hypoglycemia.html\" target=_blank>hypoglycemia</a> or a metabolic crisis. In general, it is often suggested that these infants be fed every four to six hours. Some babies need to eat even more frequently than this. It is also&nbsp;important that infants be fed during the night. They may need to be woken up to eat if they do not wake up on their own. Your metabolic doctor and dietician will give you an appropriate feeding plan for your infant.[3905]<br><br>A&nbsp;low fat, high <a href=\"http://www.newbornscreening.info/GlossaryTerms/carbohydrate.html\" target=_blank><u>carbohydrate</u></a>&nbsp;food plan is often recommended. Carbohydrates give the body many types of sugar that can be used as energy. For children needing this treatment, most food in the diet should be carbohydrates (bread, pasta, fruit, vegetables, etc.) and <a href=\"http://www.newbornscreening.info/GlossaryTerms/protein.html\" target=_blank><u>protein</u></a> (lean meat and low-fat dairy foods). Your dietician can create a food plan with the correct type and amount of fat your child needs.&nbsp;Any diet changes should be made under the guidance of an experienced dietician.[3905]&nbsp; ","dateModified":"2011-07-15T16:32:00","references":[{"referenceId":3905,"authors":"","articleTitle":"Genetic Fact Sheets for Parents: Fatty Acid Oxidation Disorders","bookWebsiteJournalTitle":"STAR-G","date":"April 2011","url":"http://www.newbornscreening.info/Parents/fattyaciddisorders/MCADD.html","dateAccessed":"2011-07-15T00:00:00"}]}]},{"caseId":25960,"abbreviatedInquiry":"I have two sons with MCAD deficiency. I was recently told by the doctor that my sons will not be able to consume any alcohol when old enough to do so because it could lead to death. I would really like more information on this.","caseQuestions":[{"questionId":3219,"questionText":"What information is available on alcohol consumption in medium-chain acyl-coenzyme A dehydrogenase (MCAD) deficiency?","answerText":"The United Mitochondrial Disease Foundation lists alcohol as a substance that people with mitochondrial disease should avoid,&nbsp;because alcohol has been known to hasten the progression of some mitochondrial disorders.[2207] In 2009, Lang reviewed several cases of MCAD deficiency diagnosed in adulthood.[2208] Many of these cases&nbsp;had alcohol consumption as a precipitating factor for an episode of metabolic crisis. Alcohol inhibits the breakdown&nbsp;(oxidation) of fatty acids in the liver, which can lead to the toxic accumulation of fatty acids within cells. In&nbsp;the cases reviewed by Lang, the consumption of alcohol also led to vomiting, which may have caused symptoms due to a period of fasting. <br><br>To learn more about the dietary guidelines&nbsp;for MCAD deficiency, we recommend that you contact the following organizations:<br><br>United Mitochondrial Disease Foundation<br>8085 Saltsburg Road, Suite 201<br>Pittsburg PA 15239<br>Toll-free: 1-888-317-UMDF <br>Telephone: 412-793-8077 <br>Fax: 412-793-6477 <br>E-mail: <a href=\"mailto:info@umdf.org\">info@umdf.org</a> <br>Web site: <a href=\"http://www.umdf.org \" target=_blank>http://www.umdf.org </a><br><br>FOD (Fatty Oxidation Disorder) Family Support Group&nbsp;<br>PO Box 54<br>Okemos, MI 48805-0054 <br>Telephone: 517-381-1940 <br>Fax: 866-290-5206<br>E-mail: <a href=\"mailto:deb@fodsupport.org\">deb@fodsupport.org <br></a>Web site: <a href=\"http://www.fodsupport.org/\" target=_blank>http://www.fodsupport.org </a>","dateModified":"2010-04-05T12:36:00","references":[{"referenceId":2207,"authors":"","articleTitle":"MitoFIRST Handbook: An Introductory Guide","bookWebsiteJournalTitle":"United Mitochondrial Disease Foundation","date":"2008","url":"http://www.umdf.org/atf/cf/%7B858ACD34-ECC3-472A-8794-39B92E103561%7D/mito_first.pdf","dateAccessed":"2010-04-05T00:00:00"},{"referenceId":2208,"authors":"Lang TF","articleTitle":"Adult presentations of medium-chain acyl-CoA dehydrogenase deficiency (MCADD)","bookWebsiteJournalTitle":"Journal of Inherited Metabolic Disease","date":"2009","url":"http://www.ncbi.nlm.nih.gov/pubmed/19821147","dateAccessed":"2010-04-05T00:00:00"}]}]},{"caseId":22838,"abbreviatedInquiry":"My sister's daughter (my niece) recently had a baby and he was diagnosed with&nbsp;medium-chain acyl-coenzyme A dehydrogenase (MCAD) deficiency.&nbsp;If this condition is traced back to my sister,&nbsp;is it important for me and/or my children (ages 8 and 11) to be tested?&nbsp;","caseQuestions":[{"questionId":1259,"questionText":"What is medium-chain acyl-coenzyme A dehydrogenase (MCAD) deficiency?","answerText":"<strong>Medium-chain acyl-coenzyme A dehydrogenase deficiency (MCADD)</strong> is an inherited metabolic disorder that prevents the body from converting certain fats to energy, particularly during periods without food (fasting). People with MCADD do not have enough of an enzyme needed to metabolize a group of fats called medium-chain fatty acids. Signs and symptoms usually begin by early childhood and may include vomiting, lack of energy, and low blood sugar (hypoglycemia). Symptoms can be triggered by periods of fasting or by illnesses.[757]<br />\r\n<br />\r\nMCADD is caused by mutations in the&nbsp;<a class=\"link-dapple\" title=\"A C A D M\" href=\"http://ghr.nlm.nih.gov/gene=acadm\" target=\"_blank\"><em>ACADM</em></a>&nbsp;gene and inheritance is <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a>.[757] Treatment includes strict avoidance of fasting and avoidance of medium chain triglycerides in the diet.[7514] If not treated, people with MCADD are at risk of serious complications including sudden death.[757]<br />","dateModified":"2017-08-29T00:00:00","references":[{"referenceId":757,"authors":"","articleTitle":"Medium-chain acyl-coenzyme A dehydrogenase deficiency","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"February, 2015","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition=mediumchainacylcoenzymeadehydrogenasedeficiency","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":7514,"authors":"Simon Olpin","articleTitle":"Medium chain acyl-CoA dehydrogenase deficiency","bookWebsiteJournalTitle":"Orphanet","date":"February, 2014","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=EN&Expert=42","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1265,"questionText":"What are the signs and symptoms of medium-chain acyl-coenzyme A dehydrogenase (MCAD) deficiency?","answerText":"The initial signs and symptoms of medium-chain acyl-coenzyme A dehydrogenase deficiency (MCADD) typically occur during infancy or early childhood and can include vomiting, lack of energy (lethargy), and low blood sugar (hypoglycemia). In rare cases, the first episode of problems related to MCADD occurs during adulthood. The signs and symptoms of MCADD can be triggered by periods of fasting, or during illnesses such as viral infections, particularly when eating is reduced. People with MCADD are also at risk of serious complications such as seizures, breathing difficulties, liver problems, brain damage, coma, and sudden, unexpected death.[757]","dateModified":"2017-08-29T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":757,"authors":"","articleTitle":"Medium-chain acyl-coenzyme A dehydrogenase deficiency","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"February, 2015","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition=mediumchainacylcoenzymeadehydrogenasedeficiency","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1423,"questionText":"What causes&nbsp;medium-chain acyl-coenzyme A dehydrogenase (MCAD) deficiency?","answerText":"MCADD is caused by mutations in the <a class=\"link-dapple\" title=\"A C A D M\" href=\"http://ghr.nlm.nih.gov/gene=acadm\" target=\"_blank\"><span><em>ACADM</em></span></a> gene. This gene gives the body instructions for making an enzyme called medium-chain acyl-CoA dehydrogenase, needed to break down fats called medium-chain fatty acids. These fatty acids are found in foods and the body's tissues, and are an important source of energy for the heart, muscles, liver, and other tissues. Mutations in this gene lead to low levels of the enzyme, which means that medium-chain fatty acids are not broken down properly. They cannot be converted to energy, leading to the symptoms of MCADD.[757]","dateModified":"2017-08-29T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":757,"authors":"","articleTitle":"Medium-chain acyl-coenzyme A dehydrogenase deficiency","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"February, 2015","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition=mediumchainacylcoenzymeadehydrogenasedeficiency","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1260,"questionText":"How is&nbsp;medium-chain acyl-coenzyme A dehydrogenase deficiency (MCADD) diagnosed?","answerText":"A diagnosis of MCADD requires an evaluation of a person's symptoms as well as the interpretation of several tests. Initial testing may include:<br />\r\n<ul>\r\n    <li>Plasma acylcarnitine</li>\r\n    <li>Urine organic acid </li>\r\n    <li>Urine acylglycine</li>\r\n</ul>\r\nFurther testing to confirm the diagnosis may include molecular genetic testing of the <em>ACADM</em> gene or biochemical genetic testing.[13748]<br />\r\n<br />\r\nMCADD is  included in many <a href=\"https://www.cdc.gov/newbornscreening/\" target=\"_blank\">newborn screening programs</a>, so a newborn with MCADD who does not yet exhibit symptoms may be diagnosed early. If a newborn screening result for MCADD is not in the normal range (\"positive\"), additional testing can then be ordered.[7514]","dateModified":"2017-08-29T00:00:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":7514,"authors":"Simon Olpin","articleTitle":"Medium chain acyl-CoA dehydrogenase deficiency","bookWebsiteJournalTitle":"Orphanet","date":"February, 2014","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=EN&Expert=42","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13748,"authors":"Matern D, Rinaldo P","articleTitle":"Medium-Chain Acyl-Coenzyme A Dehydrogenase Deficiency","bookWebsiteJournalTitle":"GeneReviews","date":"March 5, 2015","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK1424/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1424,"questionText":"How is&nbsp;medium-chain acyl-coenzyme A dehydrogenase (MCAD) deficiency inherited?","answerText":"Medium-chain acyl-coenzyme A dehydrogenase deficiency (MCADD) is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> manner.[757] This means that to have MCADD, a person must have a&nbsp;<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutation</a>&nbsp;in both copies of the responsible&nbsp;<a href=\"http://www.genome.gov/glossary/index.cfm?id=70\" target=\"_blank\">gene</a>&nbsp;in each cell. There is nothing either parent can do, before or during a pregnancy, to cause a child to have this condition.<br />\r\n<br />\r\nPeople with MCADD inherit one mutation from each of their parents. The parents, who each have one mutation, are known as&nbsp;<a href=\"https://www.genome.gov/glossary/?id=23\" target=\"_blank\">carriers</a>. Carriers of an autosomal recessive condition typically do not have any signs or symptoms (they are unaffected). When 2 carriers of an autosomal recessive condition have children, each child has a:\r\n<ul>\r\n    <li>25% chance to have the condition</li>\r\n    <li>50% chance to be an unaffected carrier like each parent</li>\r\n    <li>25% chance to be unaffected&nbsp;<em>and</em>&nbsp;not a carrier</li>\r\n</ul>","dateModified":"2017-08-29T00:00:00","resourceClassificationName":"Inheritance","references":[{"referenceId":757,"authors":"","articleTitle":"Medium-chain acyl-coenzyme A dehydrogenase deficiency","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"February, 2015","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition=mediumchainacylcoenzymeadehydrogenasedeficiency","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1426,"questionText":"What risks are posed to other members of an affected individual's family?","answerText":"The risk to other family members depends on the status of the individuals most closely related to the affected individual.&nbsp;At conception, the siblings of an affected individual have a 25% risk of being affected, a 50% risk of being asymptomatic carriers, and a 25% risk of being unaffected and not carriers. The risk could be 50% if one of the parents is also affected. Because asymptomatic parents and siblings may have MCAD deficiency, biochemical evaluation and/or molecular genetic testing should be offered to both parents and all siblings.[758]&nbsp;<br />","dateModified":"2016-06-07T00:00:00","references":[{"referenceId":758,"authors":"Matern D, Rinaldo P","articleTitle":"Medium-Chain Acyl-Coenzyme A Dehydrogenase Deficiency","bookWebsiteJournalTitle":"GeneReviews","date":"March 5, 2015","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK1424/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1425,"questionText":"Where can I learn more about the risks posed to my family members and the importance of genetic testing?","answerText":"Your family&nbsp;may benefit from consulting with a genetics professional&nbsp;who can help to determine who may be at risk&nbsp;for&nbsp;medium-chain acyl-coenzyme A dehydrogenase (MCAD) deficiency and who warrants further testing.&nbsp;\r\n<p>&nbsp;</p>","dateModified":"2016-06-07T00:00:00","references":[]},{"questionId":10322,"questionText":"How can I find a genetics professional in my area?","answerText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by&nbsp;<a href=\"https://www.genetests.org/clinics/\" target=\"_blank\">GeneTests</a>, the&nbsp;<a href=\"https://www.acmg.net/ACMG/Find_Genetic_Services/ACMG/ISGweb/FindaGeneticService.aspx?hkey=720856ab-a827-42fb-a788-b618b15079f9\" target=\"_blank\">American College of Medical Genetics</a>, and the&nbsp;<a href=\"http://nsgc.org/p/cm/ld/fid=164\" target=\"_blank\">National Society of Genetic Counselors</a>. If you need additional help,&nbsp;<a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href=\"http://ghr.nlm.nih.gov/handbook/consult?show=all\" target=\"_blank\">learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","dateModified":"2016-08-23T00:00:00","references":[]}]},{"caseId":22659,"abbreviatedInquiry":"My&nbsp;daughter had newborn screening performed at the hospital after her birth. Her doctor recently called to tell&nbsp;us that her test came back abnormal for&nbsp;medium-chain acyl-coenzyme A dehydrogenase (MCAD) deficiency.&nbsp;Are there factors that may&nbsp;contribute to a&nbsp;falsely positive result? ","caseQuestions":[{"questionId":1259,"questionText":"What is medium-chain acyl-coenzyme A dehydrogenase (MCAD) deficiency?","answerText":"<strong>Medium-chain acyl-coenzyme A dehydrogenase deficiency (MCADD)</strong> is an inherited metabolic disorder that prevents the body from converting certain fats to energy, particularly during periods without food (fasting). People with MCADD do not have enough of an enzyme needed to metabolize a group of fats called medium-chain fatty acids. Signs and symptoms usually begin by early childhood and may include vomiting, lack of energy, and low blood sugar (hypoglycemia). Symptoms can be triggered by periods of fasting or by illnesses.[757]<br />\r\n<br />\r\nMCADD is caused by mutations in the&nbsp;<a class=\"link-dapple\" title=\"A C A D M\" href=\"http://ghr.nlm.nih.gov/gene=acadm\" target=\"_blank\"><em>ACADM</em></a>&nbsp;gene and inheritance is <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a>.[757] Treatment includes strict avoidance of fasting and avoidance of medium chain triglycerides in the diet.[7514] If not treated, people with MCADD are at risk of serious complications including sudden death.[757]<br />","dateModified":"2017-08-29T00:00:00","references":[{"referenceId":757,"authors":"","articleTitle":"Medium-chain acyl-coenzyme A dehydrogenase deficiency","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"February, 2015","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition=mediumchainacylcoenzymeadehydrogenasedeficiency","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":7514,"authors":"Simon Olpin","articleTitle":"Medium chain acyl-CoA dehydrogenase deficiency","bookWebsiteJournalTitle":"Orphanet","date":"February, 2014","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=EN&Expert=42","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1265,"questionText":"What are the signs and symptoms of medium-chain acyl-coenzyme A dehydrogenase (MCAD) deficiency?","answerText":"The initial signs and symptoms of medium-chain acyl-coenzyme A dehydrogenase deficiency (MCADD) typically occur during infancy or early childhood and can include vomiting, lack of energy (lethargy), and low blood sugar (hypoglycemia). In rare cases, the first episode of problems related to MCADD occurs during adulthood. The signs and symptoms of MCADD can be triggered by periods of fasting, or during illnesses such as viral infections, particularly when eating is reduced. People with MCADD are also at risk of serious complications such as seizures, breathing difficulties, liver problems, brain damage, coma, and sudden, unexpected death.[757]","dateModified":"2017-08-29T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":757,"authors":"","articleTitle":"Medium-chain acyl-coenzyme A dehydrogenase deficiency","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"February, 2015","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition=mediumchainacylcoenzymeadehydrogenasedeficiency","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1260,"questionText":"How is&nbsp;medium-chain acyl-coenzyme A dehydrogenase deficiency (MCADD) diagnosed?","answerText":"A diagnosis of MCADD requires an evaluation of a person's symptoms as well as the interpretation of several tests. Initial testing may include:<br />\r\n<ul>\r\n    <li>Plasma acylcarnitine</li>\r\n    <li>Urine organic acid </li>\r\n    <li>Urine acylglycine</li>\r\n</ul>\r\nFurther testing to confirm the diagnosis may include molecular genetic testing of the <em>ACADM</em> gene or biochemical genetic testing.[13748]<br />\r\n<br />\r\nMCADD is  included in many <a href=\"https://www.cdc.gov/newbornscreening/\" target=\"_blank\">newborn screening programs</a>, so a newborn with MCADD who does not yet exhibit symptoms may be diagnosed early. If a newborn screening result for MCADD is not in the normal range (\"positive\"), additional testing can then be ordered.[7514]","dateModified":"2017-08-29T00:00:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":7514,"authors":"Simon Olpin","articleTitle":"Medium chain acyl-CoA dehydrogenase deficiency","bookWebsiteJournalTitle":"Orphanet","date":"February, 2014","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=EN&Expert=42","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13748,"authors":"Matern D, Rinaldo P","articleTitle":"Medium-Chain Acyl-Coenzyme A Dehydrogenase Deficiency","bookWebsiteJournalTitle":"GeneReviews","date":"March 5, 2015","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK1424/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1261,"questionText":"What is newborn screening?","answerText":"Newborn screening tests look for serious developmental, genetic, and metabolic disorders so that important action can be taken during the critical time before symptoms develop.&nbsp;<span class=\"minusOne\">Screening tests do not diagnose illnesses. They identify which babies need additional testing to confirm or rule out illnesses. Good screening tests have a low false-negative rate (if the test is normal, the child should be healthy), but may have a high false-positive rate (as many affected children as possible should test positive, even if this means many healthy children also test positive).[760]</span>\r\n<p>An abnormal result on a newborn screen means that the child should have additional testing to confirm or rule out the condition.&nbsp;If a disorder is diagnosed on follow-up testing, appropriate treatment can be started right away, before symptoms appear.[760]</p>","dateModified":"2016-06-07T00:00:00","references":[{"referenceId":760,"authors":"","articleTitle":"Newborn screening tests","bookWebsiteJournalTitle":"MedlinePlus","date":"4/27/2015","volume":"","pages":"","url":"http://www.nlm.nih.gov/medlineplus/ency/article/007257.htm","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1262,"questionText":"Are there factors which can cause a false positive test result for medium-chain acyl-coenzyme A dehydrogenase (MCAD)&nbsp;deficiency&nbsp;on newborn screen?","answerText":"The false positive rate for medium-chain acyl-coenzyme A dehydrogenase (MCAD) deficiency&nbsp;varies between screening programs because of differences in analysis of acylcarnitine (a type of fatty acid). Programs that screen for MCAD deficiency but not other fatty acid oxidation disorders often limit their analysis to octanoylcarnitine, the primary screening marker for MCAD deficiency. However, octanoylcarnitine is not specific for MCAD deficiency and is expected to be elevated in several other disorders including <a href=\"https://rarediseases.info.nih.gov/gard/6523/glutaric-acidemia-type-ii/resources/1\" target=\"_blank\">glutaric acidemia type II</a>. Consideration of other potential disorders in the differential diagnosis should minimize the false positive rate.[758]\n<p>&nbsp;</p>","dateModified":"2016-06-07T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":758,"authors":"Matern D, Rinaldo P","articleTitle":"Medium-Chain Acyl-Coenzyme A Dehydrogenase Deficiency","bookWebsiteJournalTitle":"GeneReviews","date":"March 5, 2015","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK1424/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":1264,"questionText":"What follow-up testing can be done to definitively determine if my child has medium-chain acyl-coenzyme A dehydrogenase (MCAD)&nbsp;deficiency?","answerText":"<a title=\"A C A D M\" href=\"http://ghr.nlm.nih.gov/gene=acadm\" target=\"_blank\"><em>ACADM</em></a> is the only <a href=\"http://www.genome.gov/glossary/index.cfm?id=70\" target=\"_blank\">gene</a>  known to be associated with medium-chain acyl-coenzyme A dehydrogenase (MCAD) deficiency.&nbsp;The biochemical diagnosis of MCAD deficiency can be confirmed by measurement of MCAD enzyme activity in fibroblasts or other tissues and/or by genetic testing to detect <a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a> in the <em>ACADM</em> gene.[758] <br />\r\n<br />\r\nFor more information on genetic testing for MCAD deficiency, we would recommend you consult with a genetics professional.","dateModified":"2016-06-07T00:00:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":758,"authors":"Matern D, Rinaldo P","articleTitle":"Medium-Chain Acyl-Coenzyme A Dehydrogenase Deficiency","bookWebsiteJournalTitle":"GeneReviews","date":"March 5, 2015","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK1424/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":10322,"questionText":"How can I find a genetics professional in my area?","answerText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by&nbsp;<a href=\"https://www.genetests.org/clinics/\" target=\"_blank\">GeneTests</a>, the&nbsp;<a href=\"https://www.acmg.net/ACMG/Find_Genetic_Services/ACMG/ISGweb/FindaGeneticService.aspx?hkey=720856ab-a827-42fb-a788-b618b15079f9\" target=\"_blank\">American College of Medical Genetics</a>, and the&nbsp;<a href=\"http://nsgc.org/p/cm/ld/fid=164\" target=\"_blank\">National Society of Genetic Counselors</a>. If you need additional help,&nbsp;<a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href=\"http://ghr.nlm.nih.gov/handbook/consult?show=all\" target=\"_blank\">learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","dateModified":"2016-08-23T00:00:00","references":[]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":5702,"phenoTypeName":"Decreased liver function","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":1584,"phenoTypeName":"Decreased plasma total carnitine","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":14516,"phenoTypeName":"Dicarboxylic aciduria","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5304,"phenoTypeName":"Exercise-induced myalgia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":15339,"phenoTypeName":"Fatigable weakness of neck muscles","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8115,"phenoTypeName":"Hepatomegaly","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13089,"phenoTypeName":"Hyperammonemia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8716,"phenoTypeName":"Muscular hypotonia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5281,"phenoTypeName":"Proximal muscle weakness","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9404,"phenoTypeName":"Reduced tendon reflexes","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13400,"phenoTypeName":"Vomiting","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":6761,"phenoTypeName":"Abnormal lactate dehydrogenase level","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11774,"phenoTypeName":"Arrhythmia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8720,"phenoTypeName":"Ataxia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13458,"phenoTypeName":"Bilateral tonic-clonic seizure","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":3609,"phenoTypeName":"Cachexia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8971,"phenoTypeName":"Cardiomegaly","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8702,"phenoTypeName":"Coma","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":14142,"phenoTypeName":"Delayed speech and language development","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13401,"phenoTypeName":"Diarrhea","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":15089,"phenoTypeName":"Distal arthrogryposis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4319,"phenoTypeName":"Elevated hepatic transaminase","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10933,"phenoTypeName":"Elevated serum creatine kinase","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":428,"phenoTypeName":"Elevated urinary 3-hydroxybutyric acid","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":7963,"phenoTypeName":"Exertional dyspnea","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13704,"phenoTypeName":"Fatigue","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11446,"phenoTypeName":"Febrile seizure (within the age range of 3 months to 6 years)","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5695,"phenoTypeName":"Hepatic steatosis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13041,"phenoTypeName":"Hypoglycemia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13048,"phenoTypeName":"Ketosis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8721,"phenoTypeName":"Lethargy","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8511,"phenoTypeName":"Loss of consciousness","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9851,"phenoTypeName":"Macrocephaly","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5588,"phenoTypeName":"Muscle spasm","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":14500,"phenoTypeName":"Myopathy","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":14505,"phenoTypeName":"Skeletal muscle atrophy","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4,"phenoTypeName":"Autosomal recessive inheritance","percentRanges":"-"},{"phenoTypeId":13855,"phenoTypeName":"Cerebral edema","percentRanges":"-"},{"phenoTypeId":10926,"phenoTypeName":"Decreased plasma carnitine","percentRanges":"-"},{"phenoTypeId":9384,"phenoTypeName":"Generalized hypotonia","percentRanges":"-"},{"phenoTypeId":8723,"phenoTypeName":"Global developmental delay","percentRanges":"-"},{"phenoTypeId":14556,"phenoTypeName":"Hyperglycinuria","percentRanges":"-"},{"phenoTypeId":15609,"phenoTypeName":"Medium chain dicarboxylic aciduria","percentRanges":"-"},{"phenoTypeId":8719,"phenoTypeName":"Seizure","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Medium-chain_acyl-coenzyme_A_dehydrogenase_deficiency"}